Hemodynamic changes during intrathecal anesthesia with different Bupivacaine concentration in patients undergoing transurethral resection of prostate
Not Applicable
Not yet recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR202304886237340
- Lead Sponsor
- sherif kamal hafez arafa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 90
Inclusion Criteria
1-Age: more than 50 years old
2- with prostate surgerySex:male
3- (ASA): I-II
4- Operation: Prostate surgery
Exclusion Criteria
-ASA :III-IV
-Patient refusal
-Contraindications to regional anesthesia bleeding tendency
-Allergy to local anesthetics or opioids
-lumber vertebra anomaly
-Failed cases (failure of sensory level block)
-Respiratory disorder
-Morbid obese with comorbidities
-Hepatic patient (bleeding disorder)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain bupivacaine's hemodynamic effects during intrathecal anesthesia for TURP?
How does intrathecal bupivacaine concentration affect hemodynamic stability compared to standard-of-care spinal anesthetics in urological surgery?
Are there specific biomarkers that predict hemodynamic response to varying bupivacaine concentrations in spinal anesthesia for prostate procedures?
What are the potential adverse hemodynamic events associated with high-concentration bupivacaine intrathecal use in TURP patients and their management?
How do combination approaches of bupivacaine with adjuvants like clonidine or epinephrine influence hemodynamic outcomes in spinal anesthesia for transurethral prostate resection?